Featured News

This month's story comes from Brett Spitale, CDF's Chief of Staff, and special guest appearance from his son, Maxwell!

The Celiac Disease Foundation is delighted to be an Official Charity Partner for the 2024 Los Angeles Marathon. On March 17, six dedicated Team Gluten-Free® runners will come together to conquer 26.2 miles, all with a shared mission – raising crucial funds to advance the diagnosis, treatments, and finding a cure for celiac disease.

In our pursuit of critical federal support for celiac disease, we understand that true progress requires a multifaceted approach. While government support is invaluable, we also recognize the power of strategic collaboration with the private sector to drive the much-needed change our community deserves.

Chugai Pharmaceutical Co., Ltd. recently published encouraging results from a non-clinical study on DONQ52, an experimental medication for celiac disease. The findings show its potential to block the immune response to gluten in celiac disease without affecting the rest of the immune system.  

The Celiac Disease Foundation is proud to announce that Robert Anderson, MB, ChB, PhD, has joined the Foundation as its Principal Science & Innovation Advisor. In his new role, Dr. Anderson will draw on his extensive background to provide scientific expertise and guidance to the organization and its stakeholders.  

Looking for a delicious gluten-free sandwich? Look no further than Proud Sponsor Life Cuisine's Chicken Bacon Ranch Piada, made with cauliflower crust and 18g of protein. Feed your best gluten free life with Life Cuisine!

Otorhinolaryngological (ORL) – better known as ear, nose, and throat – complaints in celiac disease are considered rare and are often overlooked by physicians. A recent international narrative review analyzed the latest evidence on the association among celiac disease, ORL, and esophageal symptoms. 

The Celiac Disease Foundation today announced its Board of Directors re-appointments for 2024. The Board represents a diverse mix of professionals, patients, and caregivers who are deeply committed to advancing the Foundation’s mission of accelerating diagnosis, treatments, and a cure for celiac disease.  

The Celiac Disease Foundation is expanding its operations with the appointment of three senior-level staff. These roles are aligned with the Foundation’s latest strategic plan and ongoing work to accelerate diagnosis, treatments, and a cure for celiac disease – one of the world’s most prevalent genetic autoimmune diseases.

On behalf of the entire celiac disease patient community, thank you for your participation in the Celiac Disease Foundation’s 2023 Gift of Hope campaign! Our annual year-end initiative to raise awareness and funds for celiac disease research was extraordinary – all thanks to YOU.